KALV Earnings History
KalVista Pharmaceuticals, Inc. (KALV) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.44B, listed on NASDAQ, employing roughly 275 people, carrying a beta of -0.29 to the broader market. KalVista Pharmaceuticals, Inc. Led by Benjamin L. Palleiko, public since 2015-04-09.
KalVista Pharmaceuticals, Inc. has beat EPS estimates in 1 of the last 6 quarters.
| Date | EPS Est. | EPS Actual | Surprise | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Dec 3, 2026 | -0.29 | N/A | N/A | $48.7M | N/A |
| Aug 13, 2026 | -0.29 | N/A | N/A | $48.2M | N/A |
| May 15, 2026 | -0.38 | -0.92 | N/A | $39.0M | $13.7M |
| Mar 24, 2026 | -0.54 | -1.01 | N/A | $5.4M | $1.4M |
| Nov 10, 2025 | -0.96 | -0.92 | N/A | $32.3M | $13.7M |
| Sep 11, 2025 | -0.91 | -1.12 | N/A | $713.8K | $1.4M |
What KALV's Earnings History Tells Options Traders
KalVista Pharmaceuticals, Inc. has missed estimates more often than it has beat them (only 1 beats in 6 reports). Names with poor beat-rate history typically carry richer downside skew going into earnings and produce larger post-event moves on misses, conditions where put-spread or long-vol structures may carry edge over premium-selling. Beat rate is one input to event-driven sizing; pair it with the implied-vs-realized volatility view, the current IV rank, and the put-call skew going into the print. Surprise magnitude matters as much as direction - an in-line beat with conservative guidance can produce a larger negative move than a missed quarter with raised forward guidance. The earnings table above shows the most recent six reported quarters; for the full multi-year history including revenue growth trajectory and EPS guidance trends, the per-ticker fundamentals view aggregates the underlying GAAP filings.
How Earnings Drive KALV Options Pricing
Earnings events are the largest single driver of single-name implied volatility in equity options markets. Pre-event, IV inflates over the two-to-three week run-up as the binary uncertainty of the print compounds; the IV rank typically peaks the day before the announcement. Post-event, IV crushes back toward the realized-volatility baseline as uncertainty resolves. The magnitude of the crush depends on how stretched pre-event IV was relative to the eventual realized move - an oversized pre-event IV with an undersized realized move produces the cleanest premium-selling outcome, while a stretched IV that still under-prices a tail move on the print produces the cleanest long-vol outcome.
The catalyst calendar for KALV matters beyond the headline EPS surprise. Forward guidance revisions, capital-allocation changes (dividend hikes, buyback authorizations, M&A announcements), and segment-level performance discussions can drive larger post-event moves than the headline beat or miss. Pair the earnings beat-rate read above with the upcoming-event calendar and the IV-rank view to size pre-event and post-event positioning; for short-vol structures the goal is to be long premium-rich and to harvest the IV crush, while for long-vol structures the goal is to own gamma cheap into a regime where the realized move is likely to exceed the implied move.